DuPont (DD) insider plans Rule 144 sale of 9,011 common shares
Rhea-AI Filing Summary
DuPont de Nemours, Inc. insider plans to sell recently exercised shares under Rule 144. A holder intends to sell 9,011 shares of DuPont common stock through Merrill Lynch on the NYSE, with an aggregate market value of $355,591.21 as disclosed in the notice. The shares relate to DuPont, which had 418,975,324 common shares outstanding at the time referenced in the form.
The securities to be sold were acquired on 11/28/2025 through the exercise of employee stock options in a broker-assisted cashless transaction, meaning option exercise and sale are coordinated. The person for whose account the shares are to be sold represents that they are not aware of any material adverse, nonpublic information about DuPont’s current or prospective operations.
Positive
- None.
Negative
- None.
FAQ
What does DuPont (DD) disclose in this Form 144 notice?
The notice states that an insider plans to sell 9,011 shares of DuPont common stock under Rule 144 through Merrill Lynch on the NYSE, with an aggregate market value of $355,591.21.
How were the DuPont (DD) shares being sold under Rule 144 acquired?
The 9,011 shares of DuPont common stock were acquired on 11/28/2025 through the exercise of employee stock options in a broker-assisted cashless exercise.
What is the approximate sale date for the DuPont (DD) shares in this Form 144?
The Form 144 indicates an approximate date of sale of 11/28/2025 for the 9,011 DuPont common shares to be sold on the NYSE.
What is the aggregate market value of DuPont (DD) shares covered by this Form 144?
The notice reports an aggregate market value of $355,591.21 for the 9,011 DuPont common shares proposed to be sold.
How many DuPont (DD) shares were outstanding according to this Form 144?
The Form 144 lists 418,975,324 shares of DuPont common stock as outstanding, which is a baseline figure for the company’s equity.
Does the DuPont (DD) Form 144 include a representation about nonpublic information?
Yes. The person for whose account the securities are to be sold represents that they do not know any material adverse information about DuPont’s current or prospective operations that has not been publicly disclosed.